AMS (American Medical Systems) prices convertible debt offering:
This article was originally published in Clinica
American Medical Systems (AMS) last week priced $325m worth of convertible senior subordinated notes that will mature in 2036. The notes will be convertible either into cash or AMS shares, depending on the circumstances, said the Minneapolis, Minnesota company. The firm plans to use the net proceeds from the offering to fund part of its proposed $715m purchase of San Jose, California-based Laserscope (see Clinica No 1209, p 16), as well as for general working capital purposes. Should the Laserscope transaction fall through, AMS said it would use the proceeds for other possible acquisitions.
You may also be interested in...
Can shaving ever be “friction free”? Not according to Procter & Gamble, which challenged in a complaint to the UK Advertising Standards Authority a claim made by a British cosmetics firm FFS that it provided a “friction free” shaving experience for women via its subscription razor service.
Work has started on UK-only regulations for the medtech and medicines sectors, to ensure that the regulatory framework not only functions but can also react swiftly to needs after the UK leaves the EU. This article is part two of two.